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Introduction
============

The neural cell adhesion molecule (NCAM) is involved in several morphogenetic events, such as neuronal migration and differentiation, neurite outgrowth, and axon fasciculation. NCAM-induced morphogenetic effects depend on activation of Src family tyrosine kinases and, in particular, p59^fyn^ kinase ([@bib37]). NCAM-dependent neurite outgrowth is impaired in neurons from p59^fyn^-deficient mice ([@bib1]) and is abolished by inhibitors of Src kinase family members ([@bib10]; [@bib26]; [@bib8])~.~ The NCAM140 isoform has been observed in a complex with p59^fyn^, whereas p59^fyn^ does not associate significantly with NCAM180 or glycosylphosphatidylinositol-linked NCAM120 ([@bib2])~.~ However in oligodendrocytes, p59^fyn^ is also associated with NCAM120 in isolated lipid rafts ([@bib27]), whereas in tumor cells NCAM is also associated with pp60^c-src^ ([@bib8]), suggesting that additional molecular mechanisms may define NCAM\'s specificity of interactions with Src kinase family members. Several lines of evidence suggest that NCAM\'s association with lipid rafts is critical for p59^fyn^ activation. NCAM not only colocalizes with p59^fyn^ in lipid rafts ([@bib19]) but disruption of NCAM140 association with lipid rafts either by mutation of NCAM140 palmitoylation sites or by lipid raft destruction attenuates activation of the p59^fyn^ kinase pathway, completely blocking neurite outgrowth ([@bib32]). However, in spite of compelling evidence that NCAM can activate Src family tyrosine kinases, the mechanism of this activation has remained unclear.

The activity of Src family tyrosine kinases is regulated by phosphorylation ([@bib5]; [@bib41]; [@bib3]; [@bib21]; [@bib34]). The two best-characterized tyrosine phosphorylation sites in Src family tyrosine kinases perform opposing regulatory functions. The site within the enzyme\'s activation loop (Tyr-420 in p59^fyn^) undergoes autophosphorylation, which is crucial for achieving full kinase activity. In contrast, phosphorylation of the COOH-terminal site (Tyr-531 in p59^fyn^) inhibits kinase activity through intramolecular interaction between phosphorylated Tyr-531 and the SH2 domain in p59^fyn^, which stabilizes a noncatalytic conformation.

A well known activator of Src family tyrosine kinases is the receptor protein tyrosine phosphatase RPTPα ([@bib52], [@bib53]; [@bib13]; [@bib39]; [@bib36]). It contains two cytoplasmic catalytic domains, D1 and D2, of which only D1 is significantly active in vitro and in vivo ([@bib46]; [@bib13]; [@bib48]; [@bib18]). To activate Src family tyrosine kinase, constitutively phosphorylated pTyr789 at the COOH-terminal of RPTPα binds the SH2 domain of Src family tyrosine kinase that disrupts the intra-molecular association between the SH2 and SH1 domains of the kinase. This initial binding is followed by binding between the inhibitory COOH-terminal phosphorylation site of the Src family tyrosine kinase (pTyr531 in p59^fyn^) and the D1 domain of RPTPα resulting in dephosphorylation of the inhibitory COOH-terminal phosphorylation sites in Src family tyrosine kinases ([@bib53]). These sites are hyperphosphorylated in cells lacking RPTPα, and kinase activity of pp60^c-src^ and p59^fyn^ in RPTPα-deficient mice is reduced ([@bib36]). Like p59^fyn^ and NCAM, RPTPα is particularly abundant in the brain ([@bib25]; [@bib28]), accumulates in growth cones ([@bib20]), and is involved in neural cell migration and neurite outgrowth ([@bib39]; [@bib49]; [@bib35]).

Remarkably, a close homologue of RPTPα, CD45, associates with the membrane-cytoskeleton linker protein spectrin ([@bib31]; [@bib22]), a binding partner of NCAM ([@bib30]). Following this lead, we investigated the possibility that RPTPα is involved in NCAM-induced p59^fyn^ activation. We show that the intracellular domains of NCAM140 and RPTPα interact directly and that this interaction is enhanced by spectrin-mediated Ca^2+^-dependent cross-linking of NCAM and RPTPα. Levels of p59^fyn^ associated with NCAM correlate with the ability of NCAM-associated RPTPα to bind to p59^fyn^, and the NCAM--p59^fyn^ complex is disrupted in RPTPα-deficient brains implicating RPTPα as linker molecule between NCAM and p59^fyn^. RPTPα redistributes to lipid rafts in response to NCAM activation and RPTPα levels are reduced in lipid rafts from NCAM-deficient mice, suggesting that NCAM recruits RPTPα to lipid rafts to activate p59^fyn^. Finally, NCAM-mediated p59^fyn^ activation is abolished in RPTPα-deficient neurons and NCAM-induced neurite outgrowth is blocked in RPTPα-deficient neurons or neurons transfected with dominant-negative RPTPα mutants, demonstrating that RPTPα is a major phosphatase involved in NCAM-mediated signaling.

Results
=======

Activation of p59^fyn^ is impaired in NCAM-deficient brains
-----------------------------------------------------------

Cross-linking of NCAM at the cell surface results in a rapid activation of p59^fyn^ kinase ([@bib2]; [@bib32]) via an unknown mechanism. To analyze whether or not NCAM deficiency may affect the activation status of p59^fyn^, we compared levels of activated p59^fyn^ characterized by dephosphorylation at Tyr-531 and phosphorylation at Tyr-420 in the brains of wild-type and NCAM-deficient mice. Whereas the level of p59^fyn^ protein was higher in brain homogenates of NCAM-deficient mice ([Fig. 1](#fig1){ref-type="fig"} A), labeling with antibodies recognizing only p59^fyn^ dephosphorylated at Tyr-531 or with antibodies recognizing only p59^fyn^ phosphorylated at Tyr-420 was reduced in brain homogenates of NCAM-deficient mice ([Fig. 1](#fig1){ref-type="fig"} B), indicating that activation of p59^fyn^ is inhibited in NCAM-deficient brains and suggesting that NCAM is involved in the regulation of p59^fyn^ function.

![**Activated p59^fyn^ is reduced in NCAM-deficient brain.** (A) Brain homogenates from 0- to 4-d-old wild-type (NCAM+/+) and NCAM-deficient (NCAM−/−) mice were probed by Western blot with antibodies against total p59^fyn^ protein. Labeling for GAPDH was included as loading control. Levels of p59^fyn^ protein are increased in NCAM-deficient brains. (B) p59^fyn^ immunoprecipitates from 0- to 4-d-old wild-type (NCAM+/+) and NCAM-deficient (NCAM−/−) mice were probed by Western blot with antibodies against total p59^fyn^ protein, p59^fyn^ dephosphorylated at Tyr-531, or p59^fyn^ phosphorylated at Tyr-420. Activated p59^fyn^ is reduced in NCAM-deficient brains. Histograms (A and B) show quantitation of the blots with OD for wild type set to 100%. Mean values ± SEM (*n* = 6) are shown. \*, P \< 0.05, paired *t* test.](200405073f1){#fig1}

NCAM forms a complex with RPTPα
-------------------------------

The intracellular domain of NCAM does not contain sequences known to induce p59^fyn^ activation. Thus, NCAM may form a complex with a protein, possibly a protein tyrosine phosphatase, to activate p59^fyn^. One possible candidate is the RPTPα that dephosphorylates Tyr-531 of p59^fyn^ ([@bib3]) and is highly enriched in neurons and growth cones ([@bib20]). Remarkably, in RPTPα-deficient cells, both dephosphorylation of the COOH-terminal tyrosine residue and autophosphorylation of the tyrosine residue within the activation loop of pp60^c-src^ is reduced ([@bib44]), resembling the phenotype of NCAM-deficient mice. Furthermore, a close homologue of RPTPα, CD45, associates with the membrane-cytoskeleton linker protein spectrin ([@bib31]; [@bib22]), a binding partner of NCAM ([@bib30]). To investigate if NCAM interacts with RPTPα, we analyzed the distribution of both proteins in cultured hippocampal neurons. NCAM and RPTPα partially colocalized along neurites, and both proteins accumulated in growth cones where clusters of NCAM partially overlapped with accumulations of RPTPα ([Fig. 2](#fig2){ref-type="fig"} A). To verify whether or not NCAM interacts with RPTPα, we induced clustering of NCAM at the cell surface of live hippocampal neurons by incubation with antibodies against NCAM. Clustering of NCAM enhanced overlap between NCAM and RPTPα localization (mean correlation between NCAM and RPTPα localization being 0.3 ± 0.05 and 0.6 ± 0.03 in neurons treated with nonspecific IgG or NCAM antibodies, respectively; [Fig. 2](#fig2){ref-type="fig"} B), indicating that RPTPα partially redistributed to NCAM clusters and suggesting that NCAM and RPTPα form a complex. Because antibodies against RPTPα were directed against its intracellular domain, RPTPα contained in intracellular organelles could have been recognized as colocalizing with NCAM that associates with intracellular organelles of trans-Golgi network origin ([@bib40]). Thus, the redistribution of RPTPα to NCAM clusters may represent redistribution of intracellular carriers containing RPTPα. To analyze whether or not NCAM associates with RPTPα in the plasma membrane, we transfected neurons with RPTPα containing the HA tag in the extracellular domain and induced clustering of NCAM and HA-RPTPα with antibodies against NCAM and the HA tag. HA-RPTPα partially redistributed to NCAM clusters ([Fig. 2](#fig2){ref-type="fig"} C), indicating that both proteins form a complex at the cell surface.

![**NCAM forms a complex with RPTPα.** (A) High magnification image of a growth cone of a hippocampal neuron labeled with antibodies against NCAM and RPTPα. Note that clusters of NCAM overlap with accumulations of RPTPα. (B) Live hippocampal neurons were treated with nonspecific IgG or with antibodies against NCAM. Note that antibodies against NCAM induced clustering of NCAM at the cell surface. Labeling with antibodies against RPTPα showed that RPTPα partially redistributed to NCAM clusters (arrows). The corresponding profiles show NCAM and RPTPα labeling intensities along neurites. Note increased overlap of NCAM and RPTPα clusters in neurons treated with NCAM antibodies. (C) Hippocampal neurons transfected with wild-type RPTPα containing an HA tag extracellularly were incubated live with antibodies against the HA tag and NCAM. Cell surface RPTPα partially redistributed to NCAM clusters (arrows). Bars, 10 μm. (D) Brain homogenates of wild-type (NCAM+/+) and NCAM-deficient (NCAM−/−) mice (total brain) and NCAM immunoprecipitates (IP: NCAM) were probed with antibodies against RPTPα by Western blot. Labeling for GAPDH was included as loading control. RPTPα coimmunoprecipitates with NCAM. Note increased expression of RPTPα in NCAM-deficient brains. Histogram shows quantitation of the RPTPα level in wild type (+/+) and NCAM-deficient (−/−) brains. OD for wild type was set to 100%. Mean values ± SEM (*n* = 6) are shown. \*, P \< 0.05, paired *t* test.](200405073f2){#fig2}

Finally, we examined the association between NCAM and RPTPα in the brain by coimmunoprecipitation. RPTPα coimmunoprecipitated with NCAM from brain homogenates ([Fig. 2](#fig2){ref-type="fig"} D), confirming that NCAM associates with RPTPα. Interestingly, we found that the level of RPTPα was approximately two times higher in the brain of NCAM-deficient mice when compared with wild-type mice ([Fig. 2](#fig2){ref-type="fig"} D), indicating a functional relationship between NCAM and RPTPα.

NCAM140 is the most potent RPTPα-binding NCAM isoform
-----------------------------------------------------

To identify the NCAM isoform interacting with RPTPα, we expressed NCAM120, NCAM140, and NCAM180 in CHO cells and analyzed their association with RPTPα by coimmunoprecipitation. CHO cells endogenously express RPTPα that was detected with RPTPα antibodies as a band with a molecular mass identical to RPTPα detected in brain homogenates (unpublished data). Although transfected CHO cells expressed NCAM120, NCAM140, and NCAM180 in similar amounts, RPTPα coimmunoprecipitated only with NCAM140 ([Fig. 3](#fig3){ref-type="fig"} A). However, after prolonged exposure of the film we could also detect RPTPα in NCAM180 immunoprecipitates (unpublished data). RPTPα did not coimmunoprecipitate with NCAM120. We conclude that RPTPα associates predominantly with NCAM140 and to a lesser extent with NCAM180.

![**Intracellular domain of NCAM140 directly interacts with the intracellular domain of RPTPα.** (A) Lysates and NCAM immunoprecipitates (IP: NCAM) from CHO cells transfected with NCAM120, NCAM140, NCAM180, or GFP were probed by Western blot with antibodies against NCAM and RPTPα. Note that NCAM isoforms were expressed in approximately equal amounts whereas RPTPα immunoprecipitated only with NCAM140 but not NCAM180 or NCAM120. Labeling for GAPDH was included as loading control. (B) Intracellular domains of NCAM140, NCAM180, or CHL1 were bound to Ni-NTA agarose beads. The gel was stained with Coomassie blue and shows that approximately equal amounts of the intracellular domains of NCAM140, NCAM180, or CHL1 were bound to beads. Beads were incubated with equal concentrations of intracellular domains of RPTPα and the extent of RPTPα intracellular domain binding was determined by Western blotting using polyclonal antibodies against RPTPα. Intracellular domains of RPTPα interacted with intracellular domains of NCAM140, and to a lesser extent NCAM180, but not with intracellular domains of CHL1. (C) Intracellular domains of NCAM140, NCAM180, or CHL1 were bound to plastic and assayed by ELISA for the ability to bind increasing concentrations of RPTPα intracellular domains. Binding to BSA served as a control. Mean values (OD 405) ± SEM (*n* = 6) are shown. Intracellular domains of RPTPα bound to intracellular domains of NCAM140 and with a lower affinity to intracellular domains of NCAM180, but not to intracellular domains of CHL1.](200405073f3){#fig3}

Inability of NCAM120, the GPI-linked NCAM isoform without the intracellular domain, to bind RPTPα suggested that the intracellular domain of NCAM is involved in the formation of a complex between NCAM and RPTPα. Furthermore, the extracellular domain of NCAM (NCAM-Fc) did not bind to RPTPα in brain lysates, confirming that the extracellular domain of NCAM does not bind to RPTPα (unpublished data). To verify that the NCAM intracellular domain interacts directly with the intracellular domain of RPTPα, we analyzed binding of the recombinant intracellular domain of RPTPα to the intracellular domain of NCAM180 or NCAM140 in a pull-down assay. For comparison, the intracellular domain of CHL1, another adhesion molecule of the immunoglobulin superfamily, was used. The intracellular domain of RPTPα bound to the intracellular domain of NCAM180 or NCAM140 but not to the intracellular domain of CHL1 ([Fig. 3](#fig3){ref-type="fig"} B). Interaction between the intracellular domains of RPTPα and NCAM140 was severalfold stronger than between the intracellular domains of RPTPα and NCAM180 ([Fig. 3](#fig3){ref-type="fig"} B). To confirm this finding, we examined the direct interaction between the intracellular domains of RPTPα and NCAM180 or NCAM140 by ELISA. Intracellular domain of RPTPα bound to the intracellular domains of NCAM180 or NCAM140 in a concentration-dependent manner, with the intracellular domain of NCAM140 binding with a higher affinity than the intracellular domain of NCAM180 ([Fig. 3](#fig3){ref-type="fig"} C). No binding with the intracellular domain of CHL1 was observed ([Fig. 3](#fig3){ref-type="fig"} C). We conclude that NCAM binds directly to RPTPα via the intracellular domain, with NCAM140 being the most potent RPTPα-binding NCAM isoform.

RPTPα binds NCAM140 via the D2 domain and links NCAM140 to p59^fyn^
-------------------------------------------------------------------

To identify the part of the intracellular domain of RPTPα responsible for the interaction with NCAM140, we coexpressed, in CHO cells, NCAM140 together with the wild-type form of RPTPα (wtRPTPα), RPTPα lacking the D2 domain (RPTPαΔD2), or catalytically inactive form of RPTPα containing a mutation within the D1 catalytic domain (RPTPαC433S) and analyzed binding of NCAM140 to these RPTPα mutants by coimmunoprecipitation. All transfected RPTPα constructs contained the HA tag to distinguish them from endogenous RPTPα. As seen for endogenous RPTPα, transfected wtRPTPα coimmunoprecipitated with NCAM140 ([Fig. 4](#fig4){ref-type="fig"} A). Similar amounts of RPTPαC433S coimmunoprecipitated with NCAM140, whereas RPTPαΔD2 did not coimmunoprecipitate ([Fig. 4](#fig4){ref-type="fig"} A), indicating that the D2 domain is required for the interaction between RPTPα and NCAM140.

![**RPTPα interacts with NCAM140 via D2 domain and links NCAM140 to p59^fyn^.** (A) Lysates from CHO cells cotransfected with NCAM140 and wild-type (wt) RPTPα, RPTPαΔD2, RPTPαC433S, or GFP were probed with antibodies against HA tag and NCAM by Western blot. NCAM140 and RPTPα constructs are expressed at approximately equal amounts in transfected CHO cells. Labeling for GAPDH was included as loading control. NCAM (IP: NCAM) or RPTPα (IP: HA) immunoprecipitates were probed with antibodies against HA tag and p59^fyn^. wtRPTPα and RPTPαC433S but not RPTPαΔD2 coimmunoprecipitated with NCAM140. RPTPαC433S and RPTPαΔD2 inhibited coimmunoprecipitation of p59^fyn^ with NCAM140. p59^fyn^ coimmunoprecipitated with wtRPTPα and RPTPαΔD2 but to a lower extent with RPTPαC433S. (B) Hippocampal neurons transfected with RPTPαC433S, RPTPαΔD2, or GFP were incubated live with NCAM antibodies to cluster NCAM and fixed and labeled with antibodies against p59^fyn^. Note that redistribution of p59^fyn^ to NCAM clusters (arrows) was reduced in neurons transfected with RPTPαC433S or RPTPαΔD2. Bar, 10 μm. The corresponding profiles show NCAM and p59^fyn^ labeling intensities along transfected neurites. The histogram shows mean labeling intensity of p59^fyn^ in NCAM clusters. Transfection with RPTPαC433S or RPTPαΔD2 reduced association between p59^fyn^ and NCAM. Mean values ± SEM (*n* \> 20 neurons) are shown in arbitrary units (AU). \*, P \< 0.05, *t* test.](200405073f4){#fig4}

Remarkably, among the major NCAM isoforms, only NCAM140 forms a complex with p59^fyn^ ([@bib2]) that we found to correlate with its ability to bind RPTPα (see the previous section). RPTPα directly interacts with p59^fyn^ ([@bib3]). Accordingly, p59^fyn^ coimmunoprecipitated with wtRPTPα from transfected CHO cells ([Fig. 4](#fig4){ref-type="fig"} A). Approximately the same amount of p59^fyn^ coimmunoprecipitated with RPTPαΔD2 ([Fig. 4](#fig4){ref-type="fig"} A), indicating that this truncated construct also binds p59^fyn^ probably via the D1 domain. In accordance with previous reports, p59^fyn^ showed reduced ability to bind RPTPαC433S, a catalytically inactive mutant of RPTPα ([Fig. 4](#fig4){ref-type="fig"} A; [@bib53]).

To analyze the role of RPTPα in NCAM140--p59^fyn^ complex formation, we coimmunoprecipitated p59^fyn^ with NCAM140 in the presence of RPTPα mutants. In CHO cells cotransfected with NCAM140 and wtRPTPα, p59^fyn^ coimmunoprecipitated with NCAM140 ([Fig. 4](#fig4){ref-type="fig"} A). The amount of p59^fyn^ coimmunoprecipitated with NCAM140 was reduced in cells cotransfected with RPTPαC433S ([Fig. 4](#fig4){ref-type="fig"} A), correlating with the reduced ability of this catalytically inactive RPTPα mutant to bind p59^fyn^ (see previous paragraph; [@bib53]). When NCAM140 was cotransfected with RPTPαΔD2, p59^fyn^ no longer coimmunoprecipitated with NCAM140 ([Fig. 4](#fig4){ref-type="fig"} A). Because RPTPαΔD2 binds p59^fyn^ ([Fig. 4](#fig4){ref-type="fig"} A), it is conceivable that this mutant, which does not bind NCAM140, competes with endogenous RPTPα for binding to p59^fyn^ and thus inhibits NCAM140--p59^fyn^ complex formation.

To extend this analysis to neurons, we transfected hippocampal neurons with GFP alone or cotransfected with GFP and RPTPαΔD2 or RPTPαC433S and analyzed the redistribution of p59^fyn^ to NCAM clusters after cross-linking NCAM with NCAM antibodies ([Fig. 4](#fig4){ref-type="fig"} B). In neurons transfected with RPTPαΔD2 or RPTPαC433S, the level of p59^fyn^ in NCAM clusters was reduced by ∼30% when compared with GFP only transfected cells, suggesting that RPTPαΔD2 or RPTPαC433S inhibit NCAM--p59^fyn^ complex formation by competing with endogenous RPTPα. The combined observations indicate that NCAM140--p59^fyn^ complex formation correlates with the ability of NCAM140-associated RPTPα to bind to p59^fyn^, implicating RPTPα as a linker between NCAM140 and p59^fyn^.

Association between NCAM and p59^fyn^ and NCAM-mediated p59^fyn^ activation are abolished in RPTPα-deficient neurons
--------------------------------------------------------------------------------------------------------------------

To substantiate further our finding that RPTPα is a linker protein between NCAM and p59^fyn^, we analyzed p59^fyn^ activation and association of p59^fyn^ with NCAM in RPTPα-deficient brains. As for NCAM-deficient brains, levels of p59^fyn^ dephosphorylated at Tyr-531 and levels of p59^fyn^ phosphorylated at Tyr-420 were reduced in brain homogenates of RPTPα-deficient mice ([Fig. 5](#fig5){ref-type="fig"} A), further suggesting that RPTPα plays a role in NCAM-mediated p59^fyn^ activation in the brain. To analyze the role of RPTPα in the formation of the complex between NCAM and p59^fyn^, we immunoprecipitated NCAM from wild-type and RPTPα-deficient brains and probed immunoprecipitates with antibodies against p59^fyn^. Whereas p59^fyn^ coimmunoprecipitated with NCAM from wild-type brains, p59^fyn^ did not coimmunoprecipitate with NCAM from RPTPα-deficient brains ([Fig. 5](#fig5){ref-type="fig"} B). Furthermore, when NCAM was clustered at the surface of wild-type and RPTPα-deficient cultured hippocampal neurons, levels of p59^fyn^ were significantly reduced in NCAM clusters in RPTPα-deficient neurons when compared with wild-type cells ([Fig. 5](#fig5){ref-type="fig"} C), indicating that RPTPα is required for complex formation between NCAM and p59^fyn^.

![**NCAM--p59^fyn^ complex formation and NCAM-mediated p59^fyn^ activation are abolished in RPTPα-deficient neurons.** (A) p59^fyn^ immunoprecipitates from 4-d-old wild-type (RPTPα+/+) and RPTPα-deficient (RPTPα−/−) brain homogenates were probed by Western blot with antibodies against total p59^fyn^ protein, p59^fyn^ dephosphorylated at Tyr-531, or p59^fyn^ phosphorylated at Tyr-420. Levels of p59^fyn^ dephosphorylated at Tyr-531 and p59^fyn^ phosphorylated at Tyr-420 are reduced in RPTPα-deficient brains. Histograms show quantitation of the blots with OD for wild type set to 100%. Mean values ± SEM (*n* = 6) are shown. \*, P \< 0.05, paired *t* test. (B) NCAM immunoprecipitates (IP: NCAM) from wild-type (RPTPα+/+) and RPTPα-deficient (RPTPα−/−) brain homogenates were probed with antibodies against NCAM and p59^fyn^ by Western blot. Note that p59^fyn^ coimmunoprecipitates with NCAM in wild-type but not in RPTPα-deficient brains. (C) Wild-type and RPTPα-deficient hippocampal neurons were incubated live with NCAM antibodies to cluster NCAM. Cells were fixed and labeled with antibodies against p59^fyn^. Note that redistribution of p59^fyn^ to NCAM clusters was reduced in RPTPα-deficient neurons. Bar, 10 μm. The corresponding profiles show NCAM and p59^fyn^ labeling intensities along neurites. The histogram shows mean labeling intensity of p59^fyn^ in NCAM clusters. Mean values ± SEM (*n* \> 20 neurons) are shown in arbitrary units (AU). \*, P \< 0.05, *t* test. (D) Wild-type and RPTPα-deficient hippocampal neurons were incubated live with nonspecific IgG or NCAM antibodies, and fixed and labeled with antibodies against p59^fyn^ dephosphorylated at Tyr-531. Immunofluorescence signals were inverted to accentuate the difference in immunolabeling intensities between groups. Bar, 10 μm. Note that application of NCAM antibodies increased levels of p59^fyn^ dephosphorylated at Tyr-531 in wild type, but not in RPTPα-deficient neurons. The histogram shows mean labeling intensity of p59^fyn^ dephosphorylated at Tyr-531 along neurites. Mean values ± SEM (*n* \> 20 neurons) are shown in arbitrary units (AU). \*, P \< 0.05, *t* test.](200405073f5){#fig5}

NCAM clustering at the cell surface induces rapid p59^fyn^ activation ([@bib2]). To analyze whether or not RPTPα is required for NCAM-induced p59^fyn^ activation, we treated live hippocampal neurons from wild-type and RPTPα-deficient mice with NCAM antibodies and analyzed levels of p59^fyn^ dephosphorylated at Tyr-531 along neurites of the stimulated neurons. Clustering of NCAM increased levels of Tyr-531--dephosphorylated p59^fyn^ along neurites of wild-type neurons by ∼60% ([Fig. 5](#fig5){ref-type="fig"} D). However, NCAM-mediated p59^fyn^ activation was completely abolished in RPTPα-deficient neurons ([Fig. 5](#fig5){ref-type="fig"} D), demonstrating that RPTPα is required for NCAM-mediated p59^fyn^ activation.

Formation of the complex between RPTPα and NCAM is enhanced by Ca^2+^
---------------------------------------------------------------------

Coimmunoprecipitation experiments were performed either in the presence of Ca^2+^ or with 2 mM EDTA, a Ca^2+^-sequestering agent. Whereas RPTPα coimmunoprecipitated with NCAM from brain homogenates under both conditions, coimmunoprecipitated complexes were reduced by ∼60% in the presence of EDTA ([Fig. 6](#fig6){ref-type="fig"} A), suggesting that Ca^2+^ promotes formation of the NCAM--RPTPα complex. These results are in accordance with findings of [@bib50], who found that NCAM and RPTPα did not coimmunoprecipitate in the presence of EDTA. To analyze if the direct interaction between NCAM and RPTPα is Ca^2+^ dependent, we assayed binding of the intracellular domain of NCAM140 to the intracellular domain of RPTPα by ELISA in the presence or absence of Ca^2+^ ([Fig. 6](#fig6){ref-type="fig"} B), showing that the direct interaction is Ca^2+^ independent and suggesting that additional binding partners of NCAM and/or RPTPα may enhance complex formation in a Ca^2+^-dependent manner. Spectrin, which directly interacts with the intracellular domain of NCAM ([@bib30]) and contains a Ca^2+^ binding domain ([@bib11]), is one of the possible candidates. Indeed, RPTPα coimmunoprecipitated with spectrin from brain homogenates ([Fig. 6](#fig6){ref-type="fig"} C). In the presence of 2 mM EDTA, RPTPα coimmunoprecipitating with spectrin was reduced by ∼80% ([Fig. 6](#fig6){ref-type="fig"} C), whereas coimmunoprecipitation of NCAM with spectrin did not depend on Ca^2+^ ([Fig. 6](#fig6){ref-type="fig"} C). We conclude that RPTPα directly interacts with NCAM in a Ca^2+^-independent manner. However, formation of the complex is enhanced by Ca^2+^-dependent cross-linking of NCAM140 and RPTPα via spectrin.

![**NCAM--RPTPα complex formation is enhanced by spectrin in a Ca^2^** ^**+**^ **-dependent manner.** (A) NCAM immunoprecipitates obtained from brain homogenates of wild-type mice (+/+) in the presence or absence of 2 mM EDTA were probed by Western blot with antibodies against RPTPα. NCAM-deficient brains (−/−) were taken for control. Coimmunoprecipitation of RPTPα was inhibited by EDTA application. The histogram shows quantitation of the blots. (B) Intracellular domains of NCAM140 were bound to plastic and assayed by ELISA for the ability to bind increasing concentrations of RPTPα intracellular domains in the absence of Ca^2+^ or in the presence of 2 mM Ca^2+^. Binding to BSA served as a control. Mean values (OD 405) ± SEM (*n* = 6) are shown. Binding of intracellular domains of RPTPα to intracellular domains of NCAM140 did not depend on Ca^2+^. (C) Spectrin immunoprecipitates obtained from brain homogenates of wild-type mice in the absence or presence of 2 mM EDTA were probed by Western blot with antibodies against RPTPα or NCAM. Non-immune rabbit Ig (control Ig) were used for control. Coimmunoprecipitation of RPTPα with spectrin was inhibited by EDTA, whereas coimmunoprecipitation of NCAM did not depend on Ca^2+^. Histograms show quantitation of the blots. For histograms in A and C, OD in the presence of Ca^2+^ was set to 100% and mean values ± SEM (*n* = 6) are shown. \*, P \< 0.05, paired *t* test.](200405073f6){#fig6}

The NCAM--RPTPα complex redistributes to lipid rafts after NCAM activation
--------------------------------------------------------------------------

Whereas p59^fyn^ is mainly associated with lipid rafts (van\'t [@bib43]; [@bib32]; [@bib16]), only 4--8% of all RPTPα molecules were found in lipid rafts of brain (unpublished data). In hippocampal neurons extracted with cold 1% Triton X-100 to isolate lipid rafts ([@bib32]; [@bib30]), detergent-insoluble clusters of RPTPα only partially overlapped with the lipid raft marker ganglioside GM1 ([Fig. 7](#fig7){ref-type="fig"} A), further confirming that RPTPα and p59^fyn^ are segregated at the subcellular level. Because activation of NCAM results in its redistribution to lipid rafts ([@bib30]), it may also promote redistribution of NCAM-associated RPTPα to lipid rafts and thus activate raft-associated p59^fyn^. To verify this hypothesis, we studied association of NCAM and RPTPα with lipid rafts in hippocampal neurons activated or not activated with NCAM-Fc or NCAM antibodies. In accordance with previous results ([@bib30]), application of NCAM-Fc or NCAM antibodies increased GM1 levels in detergent-insoluble clusters of NCAM, indicating that NCAM redistributed to lipid rafts ([Fig. 7](#fig7){ref-type="fig"}, A--C). Application of NCAM-Fc or NCAM antibodies also increased the level of RPTPα in NCAM clusters, indicating that NCAM activation promoted NCAM--RPTPα complex formation ([Fig. 7](#fig7){ref-type="fig"}, A--C). Furthermore, NCAM activation also increased GM1 levels in detergent-insoluble clusters of RPTPα ([Fig. 7](#fig7){ref-type="fig"} D), confirming that NCAM-associated RPTPα also redistributed to lipid rafts and suggesting that NCAM recruits RPTPα to lipid rafts. To further analyze this possibility, we compared levels of RPTPα in lipid rafts in brains of wild-type and NCAM-deficient mice. Indeed, RPTPα was reduced by ∼60% in lipid rafts isolated from NCAM-deficient brains ([Fig. 7](#fig7){ref-type="fig"} E), confirming that NCAM plays a role in RPTPα targeting to lipid rafts. The levels of p59^fyn^ were increased in NCAM-deficient lipid rafts (100% and 124 ± 7.6% in wild-type and NCAM deficient rafts, respectively) probably reflecting increased levels of p59^fyn^ in NCAM-deficient brains. Levels of GM1 were not different in lipid rafts from wild-type and NCAM-deficient brains (100% and 103.3 ± 6.8% in wild-type and NCAM-deficient rafts, respectively), showing that lipid rafts were isolated with the same efficacy from wild-type and NCAM-deficient brains ([Fig. 7](#fig7){ref-type="fig"} E).

![**NCAM activation induces redistribution of RPTPα to lipid rafts.** (A--D and F) Control hippocampal neurons and neurons incubated with corresponding reagents were extracted in cold 1% Triton X-100 and labeled with antibodies against NCAM and RPTPα together with FITC-labeled cholera toxin to visualize GM1-containing lipid rafts. (A) Note increased overlap of NCAM with RPTPα and GM1 after NCAM-Fc application when compared with control neurons (arrows). Bar, 10 μm. (B and C) Histograms show mean intensities of RPTPα and GM1 in NCAM clusters in control and NCAM-Fc (B) or NCAM antibody (C)--treated neurons. (D) Histograms show mean intensities of NCAM and GM1 in RPTPα clusters in control and NCAM antibody--treated neurons. (E) Lipid rafts obtained from wild-type (+/+) or NCAM-deficient brains (−/−) were probed by Western blot (WB) with antibodies against RPTPα or p59^fyn^ or by dot blot (DB) with cholera toxin. Note reduced amount of RPTPα in rafts from NCAM-deficient brains. The histogram shows quantitation of the RPTPα levels in lipid rafts. OD in wild type was set to 100% and mean values ± SEM (*n* = 6) are shown. \*, P \< 0.05, paired *t* test. (F) Hippocampal neurons were incubated with nonspecific IgG or NCAM antibody alone, or in the presence of BAPTA-AM or FGFR inhibitor. Graphs show mean labeling intensity of RPTPα and GM1 in NCAM clusters. Note that treatment with BAPTA-AM and FGFR inhibitor abolished redistribution of RPTPα to NCAM clusters but not redistribution of NCAM to GM1-positive rafts. Histograms (B--D and F) show mean values ± SEM (*n* \> 50) in arbitrary units (AU). \*, P \< 0.05, *t* test.](200405073f7){#fig7}

NCAM-mediated recruitment of RPTPα to lipid rafts is enhanced by NCAM-induced FGF receptor (FGFR)--dependent increase in intracellular Ca^2+^
---------------------------------------------------------------------------------------------------------------------------------------------

NCAM activation increases intracellular Ca^2+^ concentrations via a FGFR-dependent mechanism ([@bib45]; [@bib24]; [@bib23]). This increase in intracellular Ca^2+^ may account for the enhanced association between NCAM and RPTPα after NCAM activation ([Fig. 7](#fig7){ref-type="fig"}, A--D) because of spectrin-mediated cross-linking of NCAM140 and RPTPα ([Fig. 6](#fig6){ref-type="fig"}). Interestingly, NCAM activation also induces redistribution of NCAM-associated spectrin to lipid rafts ([@bib30]). To analyze the role of FGFR and Ca^2+^ in the recruitment of RPTPα to an NCAM complex, we estimated levels of RPTPα associated with NCAM following NCAM activation in control neurons and neurons incubated with BAPTA-AM, a membrane-permeable Ca^2+^ chelator ([@bib47]; [@bib8]), or a specific FGFR inhibitor ([@bib32]; [@bib30]). Whereas NCAM activation increased levels of RPTPα and GM1 in NCAM clusters ([Fig. 7](#fig7){ref-type="fig"} F), treatment with BAPTA-AM or FGFR inhibitor abolished recruitment of RPTPα to NCAM clusters in response to NCAM activation ([Fig. 7](#fig7){ref-type="fig"} F). In accordance with previous findings ([@bib30]), NCAM redistribution to lipid rafts was not affected by the FGFR inhibitor or BAPTA-AM ([Fig. 7](#fig7){ref-type="fig"} F). BAPTA-AM or FGFR inhibitor did not affect the level of RPTPα associated with NCAM under nonactivated conditions ([Fig. 7](#fig7){ref-type="fig"} F). We conclude that, whereas at resting conditions Ca^2+^ does not play a major role in the interaction between NCAM and RPTPα, NCAM-induced FGFR-dependent elevations of intracellular Ca^2+^ levels strengthen the interactions between NCAM and RPTPα in response to NCAM activation, most likely via spectrin (see the section Formation of the complex between RPTPα and NCAM is enhanced by Ca^2+^).

NCAM-induced neurite outgrowth depends on NCAM association with RPTPα
---------------------------------------------------------------------

NCAM-induced neurite outgrowth depends on p59^fyn^ activation ([@bib26]), suggesting that NCAM association with RPTPα may be involved. To analyze the role of protein tyrosine phosphatases in NCAM-induced neurite outgrowth, we incubated cultured hippocampal neurons with 100 μM vanadate, an inhibitor of these phosphatases ([@bib20]). NCAM-Fc--enhanced neurite outgrowth was abolished by vanadate, indicating that activation of protein tyrosine phosphatases is required for NCAM-mediated neurite outgrowth. Vanadate did not affect neurite outgrowth in nonstimulated neurons, indicating that vanadate does not lead to nonspecific impairments ([Fig. 8](#fig8){ref-type="fig"} A). To directly assess the role of RPTPα in NCAM-induced neurite outgrowth, we transfected hippocampal neurons with the dominant-negative mutants of RPTPα. Both, RPTPαΔD2, which does not bind NCAM but associates with p59^fyn^, and catalytically inactive RPTPαC433S, which associates with NCAM but binds p59^fyn^ with a lower efficiency than endogenous RPTPα, inhibited association of NCAM with p59^fyn^ by competing with endogenous RPTPα ([Fig. 4](#fig4){ref-type="fig"}). In neurons transfected with GFP only, stimulation with NCAM-Fc significantly enhanced neurite length when compared with control nonstimulated neurons ([Fig. 8](#fig8){ref-type="fig"} B). However, neurons transfected with RPTPαΔD2 or RPTPαC433S remained unresponsive to NCAM-Fc stimulation ([Fig. 8](#fig8){ref-type="fig"} B), indicating that RPTPα plays a major role in NCAM-induced neurite outgrowth. To confirm this finding, we analyzed NCAM-mediated neurite outgrowth in hippocampal neurons from RPTPα-deficient mice. Whereas NCAM-Fc enhanced neurite outgrowth in neurons from RPTPα wild-type littermates by ∼100%, NCAM-Fc--induced neurite outgrowth was completely abolished in RPTPα-deficient neurons ([Fig. 8](#fig8){ref-type="fig"} C), further confirming that RPTPα is required for NCAM-mediated neurite outgrowth.

![**NCAM-mediated neurite outgrowth depends on RPTPα activation.** (A) Hippocampal neurons were incubated with NCAM-Fc alone or with NCAM-Fc together with vanadate, and lengths of the longest neurites were measured. NCAM-Fc increased neurite length when compared with control neurons. Vanadate decreased neurite outgrowth in the NCAM-Fc--stimulated group to the control group level but did not affect basal neurite outgrowth over poly-[l]{.smallcaps}-lysine. (B) Hippocampal neurons transfected with GFP alone or cotransfected with GFP and RPTPαC433S or RPTPαΔD2 were incubated with NCAM-Fc after transfection and lengths of the longest neurites were measured. NCAM-Fc increased neurite lengths in GFP-transfected neurons. NCAM-Fc--stimulated neurite outgrowth was blocked in the group cotransfected with RPTPαC433S or RPTPαΔD2. (C) Lengths of the longest neurites were measured in wild-type (+/+) and RPTPα-deficient (−/−) neurons not treated or treated with NCAM-Fc. NCAM-Fc increased neurite length in wild-type but not in RPTPα-deficient neurons. For A--C, mean values ± SEM are shown (*n* \> 150 neurons; \*, P \< 0.05, *t* test). Experiments were performed two times with the same effect.](200405073f8){#fig8}

Discussion
==========

It is by now well established that in response to homophilic or heterophilic binding cell adhesion molecules of the immunoglobulin superfamily, such as NCAM, L1, or CHL1, activate Src family tyrosine kinases, and in particular pp60^c-src^ or p59^fyn^, resulting in morphogenetic events, such as cell migration and neurite outgrowth. However, the mechanisms of Src family tyrosine kinase activation in these paradigms have remained unresolved. Here, we identify a cognate activator of p59^fyn^, the receptor protein tyrosine phosphatase RPTPα, as a novel binding partner of NCAM. Activation of p59^fyn^ is reduced in NCAM-deficient mice and interaction between NCAM and p59^fyn^ is abolished in RPTPα-deficient brains. Interestingly, we found that the levels of p59^fyn^ and RPTPα are increased in NCAM-deficient brains, possibly reflecting a compensatory reaction to the decreased activity of these enzymes in the mutant and further indicating a tight functional relationship between NCAM, RPTPα, and p59^fyn^. NCAM-induced neurite outgrowth is completely abrogated in RPTPα-deficient neurons or in neurons transfected with dominant-negative RPTPα mutants, indicating that RPTPα links NCAM to p59^fyn^ both physically and functionally.

Role of Ca^2+^ in NCAM--RPTPα--p59^fyn^ complex formation
---------------------------------------------------------

Interactions between NCAM and RPTPα and NCAM--RPTPα--p59^fyn^ complex formation leading to neurite outgrowth are tightly regulated ([Fig. 9](#fig9){ref-type="fig"}). First, whereas direct interaction between NCAM and RPTPα is Ca^2+^ independent, NCAM--RPTPα complex formation is enhanced by Ca^2+^-dependent cross-linking via spectrin. Remarkably, NCAM activation results in an increase in intracellular Ca^2+^ concentration via influx through Ca^2+^ channels or release from intracellular stores, and may thus provide a positive feedback loop between NCAM activation and NCAM--RPTPα complex formation involving spectrin. RPTPα binding to spectrin may also elevate RPTPα enzymatic dephosphorylation activity ([@bib31]). Interestingly, NCAM activation also induces activation of PKC ([@bib26]; [@bib30]), which is known to phosphorylate RPTPα and stimulate its activity ([@bib15]; [@bib42]; [@bib54]). Thus, a network of activated intracellular signaling molecules may underlie the induction and maintenance of NCAM-mediated neurite outgrowth. It is interesting in this respect that the NCAM140 isoform predominates in these interactions: it interacts more efficiently with p59^fyn^ via RPTPα and enhances neurite outgrowth more vigorously than NCAM180 ([@bib32]). The structural dispositions of NCAM140 for this preference will remain to be established.

![**A proposed model of NCAM140-mediated p59^fyn^ activation cascade.** Before NCAM activation, NCAM140 and RPTPα located predominantly in raft-free areas are segregated from p59^fyn^, which predominantly associates with lipid rafts. NCAM activation induces FGFR-dependent increase in intracellular Ca^2+^ that enhances RPTPα--NCAM140 complex formation via spectrin as a cross-linking platform. Additionally, NCAM activation results in the redistribution of the complex to lipid rafts due to NCAM palmitoylation. In lipid rafts, RPTPα binds and dephosphorylates p59^fyn^ resulting in p59^fyn^ activation, which, in turn, promotes neurite outgrowth.](200405073f9){#fig9}

The role of lipid rafts
-----------------------

Additional regulation of RPTPα-mediated p59^fyn^ activation is achieved by segregation of RPTPα and p59^fyn^ to different subdomains in the plasma membrane ([Fig. 9](#fig9){ref-type="fig"}). Approximately 90% of all RPTPα molecules in the brain are located in a lipid raft-free environment and are thereby segregated from lipid raft-associated p59^fyn^ under nonstimulated conditions. Whereas segregation of receptor protein tyrosine phosphatases from their potential substrates due to targeting to different plasma membrane domains has been suggested as a general mechanism of the regulation of receptor protein tyrosine phosphatase function ([@bib34]), the mechanisms that target receptor protein tyrosine phosphatases to lipid rafts have remained unclear. We show that levels of raft-associated RPTPα in the NCAM-deficient brain are reduced, and NCAM redistribution to lipid rafts in response to NCAM activation also induces redistribution of RPTPα to lipid rafts via its NCAM association. The combined observations indicate that NCAM plays a role in recruiting NCAM-associated RPTPα to lipid rafts via NCAM palmitoylation ([@bib32]; [Fig. 9](#fig9){ref-type="fig"}) or via NCAM interaction with GPI-anchored components of lipid rafts, such as the GPI-linked GDNF receptor ([@bib33]). Investigations on the regulatory mechanisms underlying palmitoylation will be required to understand the subcellular compartment-specific distribution of the NCAM--RPTPα--p59^fyn^ complex. Furthermore, the localization of adhesion molecules and receptors will have to be elucidated in view of lipid rafts heterogeneities.

Potential role of protein tyrosine phosphatases in signaling mediated by other cell adhesion molecules
------------------------------------------------------------------------------------------------------

Besides NCAM, activation of L1 and CHL1, other cell adhesion molecules of the immunoglobulin superfamily, also results in the activation of Src family tyrosine kinases ([@bib38]; [@bib6]). As for NCAM, the intracellular domains of L1 and CHL1 do not possess structural motif for protein tyrosine phosphatase activity, suggesting that yet unidentified protein tyrosine phosphatases may be involved. Identification of protein tyrosine phosphatases associated with other cell adhesion molecules of the immunoglobulin superfamily and conjunctions with RPTPα-activated integrins ([@bib51]) will be an important next step in the elucidation of the mechanisms that cell adhesion molecules use differentially to guide cell migration and neurite outgrowth in the developing nervous system.

Materials and methods
=====================

Antibodies and toxins
---------------------

Rabbit polyclonal antibodies against NCAM ([@bib32]) were used in immunoprecipitation, immunoblotting, and immunocytochemical experiments; and rat mAbs H28 against mouse NCAM ([@bib17]) were used in immunocytochemical experiments. Both antibodies recognize the extracellular domain of all NCAM isoforms. Hybridoma clone H28 was a gift of C. Goridis (Centre National de la Recherche Scientifique UMR 8542, Paris, France). Rabbit antibodies against RPTPα were a gift of C.J. Pallen (University of British Columbia, Vancouver, Canada) or were generated as described previously ([@bib14]). Rabbit polyclonal antibodies against human erythrocyte spectrin, rabbit polyclonal antibodies against the HA tag, nonspecific rabbit immunoglobulins, and cholera toxin B subunit tagged with fluorescein to label GM1 were obtained from Sigma-Aldrich. Mouse mAbs against the HA tag (clone 12CA5) were obtained from Roche Diagnostics. Rabbit polyclonal antibodies and mouse mAbs against p59^fyn^ protein were purchased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal antibodies against Tyr-527--dephosphorylated or Tyr-416--phosphorylated pp60^c-src^ kinase that cross-react with Tyr-531--dephosphorylated or Tyr-420--phosphorylated p59^fyn^ were obtained from Cell Signaling Technology. Secondary antibodies against rabbit, rat, and mouse Ig coupled to HRP, Cy2, Cy3, or Cy5 were obtained from Dianova.

Animals
-------

To compare wild-type and NCAM-deficient mice, C57BL/6J mice and NCAM-deficient mice ([@bib9]) inbred for at least nine generations onto the C57BL/6J background were used. NCAM-deficient mice were a gift of H. Cremer (Developmental Biology Institute of Marseille, Marseille, France).To compare wild-type and RPTPα-deficient mice, RPTPα-positive and -negative littermates obtained from heterozygous breeding were used (see online supplemental material).

Image acquisition and manipulation
----------------------------------

Coverslips were embedded in Aqua-Poly/Mount (Polysciences, Inc.). Images were acquired at RT using a confocal laser scanning microscope (model LSM510; Carl Zeiss MicroImaging, Inc.), LSM510 software (version 3; Carl Zeiss MicroImaging, Inc.), and oil Plan-Neofluar 40× objective (NA 1.3; Carl Zeiss MicroImaging, Inc.) at 3× digital zoom. Contrast and brightness of the images were further adjusted in Photo-Paint 9 (Corel Corporation).

Detergent extraction of cultured neurons
----------------------------------------

Cells washed in PBS were incubated for 1 min in cold microtubule-stabilizing buffer (2 mM MgCl~2~, 10 mM EGTA, and 60 mM Pipes, pH 7.0) and extracted 8 min on ice with 1% Triton X-100 in microtubule-stabilizing buffer as described previously ([@bib29]). After washing with PBS, cells were fixed with cold 4% formaldehyde in PBS.

Colocalization analysis
-----------------------

Colocalization quantification was performed as described previously ([@bib30]). In brief, an NCAM cluster was defined as an accumulation of NCAM labeling with a mean intensity at least 30% higher than background. NCAM clusters were automatically outlined using the threshold function of the Scion Image software (Scion Corporation). Within the outlined areas the mean intensities of NCAM, RPTPα, p59^fyn^, or GM1 labeling associated with NCAM cluster were measured. The same threshold was used for all groups. All experiments were performed two to three times with the same effect. Colocalization profiles were plotted using ImageJ software (National Institutes of Health).

DNA constructs
--------------

Rat NCAM140 and NCAM180/pcDNA3 were a gift of P. Maness (University of North Carolina, Chapel Hill, NC). Rat NCAM120 (a gift of E. Bock, University of Copenhagen, Copenhagen, Denmark) was subcloned into the pcDNA3 vector (Invitrogen) by two EcoRI sites. The EGFP plasmid was purchased from CLONTECH Laboratories, Inc. cDNAs encoding intracellular domains of NCAM140 and NCAM180 were as described previously ([@bib40]; [@bib30]). The plasmid encoding the intracellular domain of RPTPα was a gift of C.J. Pallen. Wild-type RPTPα, RPTPαC433S, and RPTPαΔD2 (containing RPTPα residues 1--516 \[last 6 residues: KIYNKI\]) were as described previously ([@bib12]; [@bib4]; [@bib7]).

Online supplemental material
----------------------------

Details on cultures and transfection of hippocampal neurons and CHO cells, immunofluorescence labeling, ELISA and pull-down assay, coimmunoprecipitation, isolation of lipid enriched microdomains, gel electrophoresis, immunoblotting, and generation of RPTPα-deficient mice are given in online supplemental material. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200405073/DC1>.
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